Related Experiment Video

Updated: May 18, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

CD30 expression in acute myeloid leukemia is associated with FLT3-internal tandem duplication mutation and

Amir T Fathi, Frederic I Preffer, Hossein Sadrzadeh

    Leukemia & Lymphoma
    |September 13, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
    07:38

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

    Published on: June 6, 2025

    Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
    10:21

    Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

    Published on: February 21, 2018

    Related Experiment Videos

    Last Updated: May 18, 2026

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
    09:01

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

    Published on: March 26, 2018

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
    07:38

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

    Published on: June 6, 2025

    Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
    10:21

    Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

    Published on: February 21, 2018

    Related Concept Videos

    Disorders of Leukocytes01:27

    Disorders of Leukocytes

    Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
    Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

    Articles linked to this work by shared authors, journal, and citation graph.

    Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.

    The New England journal of medicine·2026

    QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed FLT3-ITD-negative acute myeloid leukemia.

    Future oncology (London, England)·2026

    A phase 1b/2 study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML.

    Blood advances·2026

    NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026.

    Journal of the National Comprehensive Cancer Network : JNCCN·2026

    All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia.

    The New England journal of medicine·2026

    Ziftomenib with venetoclax and azacitidine for relapsed/refractory NPM1-mutated acute myeloid leukemia.

    Blood·2026

    Clinical outcomes with azole and other CYP3A4 inhibitor coadministration during venetoclax plus azacitidine or decitabine therapy in newly diagnosed acute myeloid leukemia: a systematic review and meta-analysis.

    Leukemia & lymphoma·2026

    Navitoclax monotherapy or in combination with ruxolitinib in patients with JAK2 inhibitor-treated myelofibrosis: results from the phase 2 REFINE and phase 3 TRANSFORM-2 studies.

    Leukemia & lymphoma·2026

    Evaluating YouTube videos for Hodgkin lymphoma patient education.

    Leukemia & lymphoma·2026

    Venetoclax consolidation deepens response and enables measurable residual disease-guided finite therapy in BTK inhibitor-treated chronic lymphocytic leukemia.

    Leukemia & lymphoma·2026

    Clinical outcomes of adults with PAX5-mutated or rearranged B-cell acute lymphoblastic leukemia.

    Leukemia & lymphoma·2026

    Efficacy and safety of three-drug induction-based MASPORE 2003 chemotherapy protocol in standard- and intermediate-risk pediatric acute lymphoblastic leukemia: a decade-long single-center experience from India.

    Leukemia & lymphoma·2026

    Environmental contamination with fluorouracil on floors and ceilings in antineoplastic drug preparation and nonpreparation areas of a Japanese cancer center.

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

    Exploiting Neosartorya (Aspergillus) fischeri antifungal protein 2-defined fungal targets for drug repurposing against Candida albicans.

    Microbiology spectrum·2026

    Multi-omics elucidate octapeptin mechanisms in alleviating intestinal injury in mice challenged with ETEC K88 via modulated microbial and host pathways.

    mSystems·2026

    A phosphoinositide and RAB switch controls early macropinocytosis.

    Journal of cell science·2026

    Adrenal Infections: An Underrecognized Cause of Primary Adrenal Insufficiency.

    Clinical endocrinology·2026

    Mismatch Repair Pathway, MLH1, MSH2 and Mutations in Prostate Cancer.

    International journal of surgical pathology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us